Skip to main content

Advertisement

Table 1 Clinical and demographic features of the patient groups included in the study (PA=peanut allergic patients, PS=peanut sensitized patients, C=healthy controls)

From: Use of a basophil activation test as a complementary diagnostic tool in the diagnosis of severe peanut allergy in adults

  PA (n = 47) PS (n = 22) C (n = 22)
Men 25 7 5
Women 22 15 11
Age (mean) 25 28 33
Sensitization to peanut (sIgE) 47 20 -
Sensitization to peanut (SPT) 47 18 -
Sensitization to birch (sIgE) 36 20 -
Sensitization to birch (SPT) 34 18 -
Sensitization to soy (IgE) 34 11 -
Sensitization to soy (SPT) 19 13 -
Asthma 31 11 -
Immunotherapy (birch pollen) 5 3 -
Open peanut challenge during allergy investigation 8 22 -
Peanut avoidance 47 7 -
Soy avoidance 19 5 -